Bibliographic Details
| Title: |
Phase 1 Trial of MLN0128 (Sapanisertib) and CB-839 HCl (Telaglenastat) in Patients With Advanced NSCLC (NCI 10327): Rationale and Study Design |
| Authors: |
Riess, Jonathan W., Frankel, Paul, Shackelford, David, Dunphy, Mark, Badawi, Ramsey D., Nardo, Lorenzo, Cherry, Simon R., Lanza, Ian, Reid, Joel, Gonsalves, Wilson I., Kunos, Charles, Gandara, David R., Lara, Primo N., Newman, Edward, Paik, Paul K. |
| Source: |
Clinical lung cancer. 22(1):67-70 |
| Availability: |
http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100134862199.0x000001&indx=1&recIds=ETOCvdc_100134862199.0x000001 |
| Database: |
British Library Document Supply Centre Inside Serials & Conference Proceedings |
